Ultragenyx Pharmaceutical (NASDAQ:RARE) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) in a research report report published on Wednesday, Benzinga reports. The firm currently has a $115.00 price target on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. The Goldman Sachs Group raised Ultragenyx Pharmaceutical from […]
More Stories
Barclays Boosts Canadian Pacific Kansas City (NYSE:CP) Price Target to $97.00
Canadian Pacific Kansas City (NYSE:CP – Free Report) (TSE:CP) had its price target hoisted by Barclays from $95.00 to $97.00...
Ocugen (NASDAQ:OCGN) and BioNTech (NASDAQ:BNTX) Head-To-Head Analysis
BioNTech (NASDAQ:BNTX – Get Free Report) and Ocugen (NASDAQ:OCGN – Get Free Report) are both medical companies, but which is...
Harleysville Financial (OTCMKTS:HARL) versus Burke & Herbert Financial Services (NASDAQ:BHRB) Critical Contrast
Burke & Herbert Financial Services (NASDAQ:BHRB – Get Free Report) and Harleysville Financial (OTCMKTS:HARL – Get Free Report) are both...
Financial Analysis: Terna (OTCMKTS:TERRF) and Eversource Energy (NYSE:ES)
Eversource Energy (NYSE:ES – Get Free Report) and Terna (OTCMKTS:TERRF – Get Free Report) are both utilities companies, but which...
Ultrapetrol (Bahamas) (OTCMKTS:ULTRF) & Performance Shipping (NASDAQ:PSHG) Financial Survey
Performance Shipping (NASDAQ:PSHG – Get Free Report) and Ultrapetrol (Bahamas) (OTCMKTS:ULTRF – Get Free Report) are both transportation companies, but...
B&G Foods (NYSE:BGS) Lifted to Hold at StockNews.com
StockNews.com upgraded shares of B&G Foods (NYSE:BGS – Free Report) from a sell rating to a hold rating in a...